{"disease":{"id":"vulvar-cancer","name":"vulvar cancer"},"drugs":{"marketed":[{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic vulvar cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"fytic-acid","indication_name":"Lymphoscintigraphy in cervical cancer, uterine neoplasms, vulvar cancer, and head and neck canccer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phyliance","generic_name":"fytic acid","company_name":"PDRadiopharma Inc","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00543543","title":"Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":14840,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06203106","title":"NYSCF Scientific Discovery Biobank","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"New York Stem Cell Foundation Research Institute","has_results":false},{"nct_id":"NCT04422366","title":"Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"Shanghai Bovax Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT02653118","title":"Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4453,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT00943722","title":"A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3074,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04905030","title":"Education, Immigration and HPV Vaccination: an Informational Randomized Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04425291","title":"Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1680,"lead_sponsor_name":"Shanghai Bovax Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT02628067","title":"Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1609,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT06495554","title":"Danish Vulva Cancer Recurrence Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":1295,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT03158220","title":"Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1212,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05372016","title":"Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Shanghai Bovax Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT06007625","title":"Vulvar Cancer Individualized Scoring System (VCISS)","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT01047345","title":"A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":924,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04141449","title":"A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":874,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04122235","title":"The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":755,"lead_sponsor_name":"Sorlandet Hospital HF","has_results":false},{"nct_id":"NCT06476639","title":"A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":640,"lead_sponsor_name":"Queensland Centre for Gynaecological Cancer","has_results":false},{"nct_id":"NCT02140021","title":"Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer","phase":"NA","overall_status":"TERMINATED","enrollment_count":409,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05242861","title":"Retrospective Study of Brachytherapy","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT05576831","title":"STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision","phase":"NA","overall_status":"RECRUITING","enrollment_count":249,"lead_sponsor_name":"British Columbia Cancer Agency","has_results":false},{"nct_id":"NCT00394602","title":"Chemoradiation-Induced Nausea and Emesis: Quality of Life","phase":"","overall_status":"TERMINATED","enrollment_count":207,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06023862","title":"A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":198,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT05743517","title":"Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)","phase":"NA","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT06582108","title":"UNDERSTANDING the RAREST GYNECOLOGICAL CANCERS: a MULTI -OMICS PLATFORM for IMPROVED PATIENTS MANAGEMENT","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":190,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT04028479","title":"The Registry of Oncology Outcomes Associated With Testing and Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Taproot Health","has_results":false},{"nct_id":"NCT05076942","title":"Groningen International Study on Sentinel Nodes in Vulvar Cancer-III","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":157,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT04188535","title":"Serial MRI Scans During Radiation Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":149,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT01500512","title":"Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection","phase":"","overall_status":"UNKNOWN","enrollment_count":148,"lead_sponsor_name":"Gynecologic Oncology Group","has_results":false},{"nct_id":"NCT00870233","title":"Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT01406769","title":"Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Gynecologic Oncology Group","has_results":false},{"nct_id":"NCT06029504","title":"Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer (I)","phase":"","overall_status":"RECRUITING","enrollment_count":115,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT04357873","title":"Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"UNICANCER","has_results":false},{"nct_id":"NCT05255393","title":"Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":111,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT03061435","title":"Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.","phase":"NA","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"Dr. Danielle Vicus","has_results":false},{"nct_id":"NCT02981862","title":"CaptHPV : Validation of the Method \"CaptHPV\" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Institut de Cancérologie de Lorraine","has_results":false},{"nct_id":"NCT07124000","title":"DESTINY-PANTUMOUR04","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05395962","title":"Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":92,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT06537687","title":"Relational Agents in Cervical Cancer Education (RACE)","phase":"NA","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Radhika Gogoi","has_results":false},{"nct_id":"NCT03403465","title":"Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03676101","title":"Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Shanghai Bovax Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT03339765","title":"Self-Advocacy Serious Game in Advanced Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT03346915","title":"Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Boston Medical Center","has_results":false},{"nct_id":"NCT05939440","title":"Interventions to Decrease Financial Toxicity","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT06662435","title":"GYNecologic Cancer-Related COGnitive Impairment","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT06039111","title":"Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":58,"lead_sponsor_name":"Hamilton Health Sciences Corporation","has_results":false},{"nct_id":"NCT01595061","title":"Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":57,"lead_sponsor_name":"Gynecologic Oncology Group","has_results":true},{"nct_id":"NCT04708470","title":"A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":55,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04287868","title":"Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":51,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06871787","title":"Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Istanbul University","has_results":false},{"nct_id":"NCT05995860","title":"Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care Delivery","phase":"NA","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT05903833","title":"Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":42,"lead_sponsor_name":"AGO Research GmbH","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}